Innoviva (INVA) FCF Margin (QoQ) (2011 - 2025)
Innoviva (INVA) FCF Margin (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 367.00 |
| Jun 30, 2025 | -1,090.00 |
| Sep 30, 2024 | 464.00 |
| Jun 30, 2024 | -144,168.00 |
| Sep 30, 2023 | -130,274.00 |
| Jun 30, 2023 | -3,817.00 |
| Sep 30, 2022 | -185,101.00 |
| Jun 30, 2022 | -248,506.00 |
| Sep 30, 2021 | -299,696.00 |
| Jun 30, 2021 | -226,678.00 |
| Mar 31, 2021 | -1.16 Mn |
| Dec 31, 2020 | 1.68 Mn |
| Sep 30, 2020 | -1,701.00 |
| Jun 30, 2020 | 770.00 |
| Mar 31, 2020 | 533.00 |
| Dec 31, 2019 | 75.00 |
| Sep 30, 2019 | -83.00 |
| Jun 30, 2019 | -5,078.00 |
| Mar 31, 2019 | 6,155.00 |
| Dec 31, 2018 | -2,010.00 |